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ELI THOMAS BETTIGA: Synthesis of Novel Long Chain Unsaturated Fatty Acid Analogues of 
Capsaicin 
(Under the direction of John M. Rimoldi) 
 
A number of key studies have shown that the natural product capsaicin displays in vitro 
and in vivo antitumor effects against a variety of cancers, however, both the analgesic and 
cancer-related therapeutic potential of capsaicin have been limited by its unpleasant pungent side 
effects and modest potency.   N-acyl vanillylamides (N-AVAMs) are a unique class of 
compounds that are simple side chain modified capsaicin derivatives.  Limited structure-activity 
relationship (SAR) studies of N-AVAMs demonstrated that substitution of the capsaicin side-
chain with longer unsaturated fatty acid groups results in non-pungent analogs with improved 
anti-invasive activity relative to capsaicin.   In an effort to ultimately create and test new analogs 
for in vitro and in vivo biological evaluation studies this project is centered on the synthesis of 
rare and unique N-AVAMs composed of -linoleic acid (GLA, 10) and stearidonic acid (SDA, 
11), rare -3 fatty acids that are reported to be found in high concentrations in the dietary 
supplements Echium seed oil and Ahiflower oil.   Each of these oils were evaluated indirectly for 
GLA and SDA content by invoking a chemical capture reaction using the plant oils as stand-
alone reagents in a condensation reaction with vanillamine. The products obtained were purified 
and analyzed using a combination of analytical techniques, including mass spectrometry and 
NMR spectroscopy.  Although the research was disrupted by COVID-19, the preliminary results 
obtained from these studies suggest that natural product oils may be a valuable source of rare 
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The natural product capsaicin (1) the active pungent component from hot chili peppers is 
used in many over-the-counter topical formulations to treat pain and inflammation (Figure 1).  
Qutenza® (capsaicin) 8% topical system was approved by the FDA in 2009 and indicated for the 
management of neuropathic pain associated with postherpetic neuralgia.  In 2020, an expanded 
indication was approved use in adults for the treatment of neuropathic pain associated with 
postherpetic neuralgia (PHN) and for neuropathic pain associated with diabetic peripheral 
neuropathy (DPN) of the feet. Capsaicin analgesic activity is mediated by the transient receptor 
potential vanilloid (TRPV) receptor superfamily of ion-channel receptors on target cells, 
specifically the TRPV1 receptor, of which capsaicin is a potent agonist (Benítez-Angeles et al., 
2020). When capsaicin binds to this receptor (Elokely et al., 2016) it results in a cascade of 
cellular signaling events that leads to the downregulation of the neuropeptide Substance P, 
involved in the inflammatory response through interaction with nociceptive nerve endings and 
cytokines. This process essentially turns off the affected nociceptive fibers, leading to a decrease 
in the sensation of pain.  
 
Figure 1: Capsaicin (1) 
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Structure Activity Relationship (SAR) studies of capsaicin have been conducted in an 
attempt to identify key structural motifs responsible for its TRPV receptor activity and to create 
novel analogs that display improved potency and efficacy (Thomas et al., 2011).  Capsaicin 
comprises two structural regions; an aromatic vanillin amine core and a long chain alkyl 
hydrophobic side chain linked by an amide group.  Synthetic and natural product derivatives 
have been evaluated to select for greater analgesic activities while decreasing off-target effects 
(Wrigglesworth et. al, 1996; Suh et al., 2005; Huang et al., 2013).   
 
Capsaicin and its anticancer activity 
 Numerous studies have shown that capsaicin and its structurally similar analogs display 
potent in vitro and in vivo antitumor effects against human cancers; these findings have been 
extensively reviewed (Freidman et al., 2018; Richbart et al., 2021).  The anticancer activity of 
capsaicin has been confirmed in a number of human cancers including breast, lung, prostate, 
gastric, renal, and hepatocellular carcinoma (Friedman et al, 2019) and is mediated by TRPV-
dependent and TRPV-independent mechanisms.  Capsaicin also modulates tumor angiogenesis 
and metastasis; two key processes in cancer progression (Min et al., 2004).  To much surprise, 
capsaicin’s mechanism to downregulate tumor angiogenesis does not involve the TRPV1 
receptor that is responsible for its analgesic effects. The antiproliferative properties of capsaicin 
is derived from its ability to block multiple survival pathways that are vital to cancer progression 
including epithelial-mesenchymal transition (EMT), invasion and metastasis (Caprodossi et al, 
2011) 
Capsaicin recruits numerous growth inhibitory signaling pathways, and include but are 
not limited to activation of calpain family of apoptotic proteases, disruption of mitochondrial 
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respiration, regulation of intracellular calcium, induction of apoptosis and autophagy, generation 
of reactive oxygen species (ROS), and the inhibition of transcription factors like p53, STAT3 
and NF-κB (Zhang et al., 2020).   Additionally, capsaicin can inhibit cancer progression through 
its ability to downregulate tumor angiogenesis, its primary antitumor mechanism (Chakraborty et 
al., 2014) and through its interference of pathways like epithelial-mesenchymal transition 
(EMT), invasion and metastasis (Amantini et al, 2016). A number of studies have shown 
capsaicin to be an effective chemo-and radio-sensitizer in cell lines and animal models, 
reinforcing established chemotherapy drugs and radiotherapy respectively (Zhang et al., 2020).  
 
Caveats of the analgesic and cancer-related therapeutic potential of capsaicin 
The analgesic and anticancer therapeutic potential of capsaicin have been limited by its 
physicochemical properties including its poor aqueous solubility and oral bioavailability, and 
also because of its unpleasant pungency. For example, clinical trials exploring the pain-relieving 
activity of orally administered capsaicin resulted in patients discontinuing its use due to its strong 
pungency and other adverse effects including hyperalgesia, nausea, vomiting, abdominal pain, 
and stomach cramps (Basith et al., 2016; Drewes et al., 2003). Clinical trials investigating the 
analgesic activity of orally administered capsaicin for visceral pain have shown that such 
disagreeable side effects have led to some patients discontinuing its use (Hammer 2006). The 
therapeutic potential of capsaicin as an anticancer drug also has liabilities. It has been shown to 
promote the growth of skin cancer, stomach cancer, colon cancer and gastric cancers (Bode & 
Dong 2011). Indeed, the presence of adverse side effects has led to increased interest in research 




N-AVAM analogues of capsaicin  
The compounds that belong to the N-acyl vanillylamide (N-AVAM) family of capsaicin 
mimetics represent some of the most intriguing drug leads reported. Specifically, the N-AVAM 
analogues have been studied for their functional activity, specificity and selectivity, 
pharmacokinetics, and bioavailability and represent compounds with diverse fatty acid side 
chains.  Several analogs display greater analgesic effects than capsaicin itself, although the 
antineoplastic activity of N-AVAM capsaicin analogs has only been reported in a few studies.  
The anticancer activity of N-AVAM capsaicin analogs is known to be mediated via multiple 
signaling networks.  For example, in human breast epithelial cells and in small cell lung cancer 
cells (SCLC), capsaicin’s anticancer activity is directly associated with its ability to change pro-
apoptotic calpain proteases’ functional activity. Specifically, in human SCLCs, it has been 
shown that the growth suppressive activity of N-AVAM capsaicin analogs is associated with the 
activation states of calpain 1 and calpain 2 (Friedman et al., 2018). 
Limited structure-activity relationship (SAR) studies of N-AVAM demonstrated that 
substitution of the capsaicin side-chain with longer unsaturated fatty acid groups results in non-
pungent analogs with improved anti-invasive activity relative to capsaicin in a panel of human 
small cell lung cancer cell lines.   Conversely, substitution of the acyl side chain of capsaicin 
with saturated long-chain lipophilic groups resulted in compounds devoid of activity (see Figure 
2 for structures).  For example, potent activation of the TRPV1 receptor was achieved with a 
series of C20 and C18 unsaturated N-AVAMs, while the saturated C18 analog palvanil (4) was 
inactive (Melck et al., 1999). This prevailing trend has been documented with N-AVAM analog 
evaluation in cancer cell lines.   Olvanil (6) and arvanil (9), which contain unsaturated oleic 
(C18:1) and arachidonic acid (C20:4) acyl groups respectively, retain a capsaicin-like anti-
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invasive activity (Hurley et al., 2017). Other longer chain capsaicin analogs synthesized by Dr. 
Rama Gadepalli and evaluated by our collaborator Dr. Piyali Dasgupta include those containing 
a saturated fatty acid group [stevanil (5)] and unsaturated fatty acid groups [livanil (7) and 
linvanil (8)] (Dasgupta, unpublished data). Although incomplete, studies to date suggest that 
growth-inhibition of these N-AVAM capsaicin analogs are directly proportional to both the chain 
length of the fatty acyl group and the number of double bonds present within this fatty acid side 
chain. (Richbart et al., 2021) 
  
Figure 2:  Saturated (left panel) and Unsaturated (right panel) N-acyl vanillamides (N-AVAMs) 
 
Specific Aims 
In an effort to ultimately create and test new analogs for in vitro and in vivo biological 
evaluation studies (with collaboration at Marshall University, Dr. Piyali Dasgupta), this thesis 
project is centered on the synthesis of rare and unique N-AVAMs containing long chain 
unsaturated fatty acid groups. The target compounds of interest are composed of -linoleic acid 
(GLA, 10) and stearidonic acid (SDA, 11), rare -3 fatty acids that are reported to be found in 





Figure 3:  Target N-AVAMs derived from -linoleic acid and stearidonic acid.  
 
These plant oils represent a cost-effective source to obtain unique long chain fatty acids 
(LCFAs) to be used as starting materials in the synthesis of novel capsaicin derivatives (Kobata 
et al, 2014).  Each of these oils will be evaluated indirectly for GLA and SDA content by 
invoking a chemical capture reaction using the plant oils as stand-alone reagents in a 
condensation reaction (Figure 4).  Each of the fatty acids in the source oils will be reacted with 
vanillamine producing five distinct fatty acid amides.  The amides will be purified and analyzed 
using a combination of analytical techniques, including mass spectrometry and NMR 
spectroscopy.   
 
 






The Unsaturated fatty acids γ -linoleic acid (GLA) and stearidonic acid (SDA) 
Stearidonic acid [SDA;(C18:4)] is a dietary long-chain omega-3 polyunsaturated fatty 
acid that is found in small quantities in seafood, fish oil, and in larger concentrations from a few 
select natural product seed oils (Whelan 2009). SDA dietary intake has been linked to reductions 
in cardiovascular disease, inflammation, and cancer.  γ -Linoleic acid (GLA) is an endogenous 
and dietary fatty acid found in vegetable oils with anti-inflammatory profiles (Sergeant et al., 
2016).  While GLA is commercially available and relatively inexpensive ($1/1 milligram), SDA 
is limited by availability and price. Only three commercial US suppliers offer SDA with an 
average cost of $100/1 milligram.  Echium seed oil (Echium plantagineum L.) represents a 
practical source of SDA, and is available to the public as a beauty product containing five 
polyunsaturated fatty acids (Miquel 2008). Ahiflower oil is also a good source oil for SDA and is 
available to the public as a dietary supplement. It contains five polyunsaturated fatty acids and is 
reported to contain greater quantities of SDA when compared to Echium seed oil (Table 1).  Not 
only is Ahiflower oil’s SDA percentage greater than Echium seed oil, it also is reported to 
contain the highest SDA quantities derived from natural product origin. Based on the percent 
fatty acid composition and price of Ahiflower oil capsules ($30/66 g oil), this oil represents an 









Fatty Acid Echium Seed Oil 







oleic acid   16% 6% Olvanil (6) known 417.3 
linoleic acid  19% 9% Livanil (7) known 415.3 
α-linoleic acid  30% 42% Linvanil (8) known 413.3 
γ-linoleic acid  10% 4% New 413.3 
stearidonic acid  13% 17% New 411.3 
Table 1:  Percent fatty acid composition of plant oils reported in two supplements. 
 
       
Figure 5:  Commercial sources of Echium seed oil (Health and Beauty Oils Center) and 
Ahiflower oil (Clean Machine) used in this study. 
    
Purification of fatty acids from natural product oils 
In order to access fatty acids like SDA and GLA from plant oils, we have considered 
several methods based on published accounts of long chain unsaturated fatty acid analysis, 
purification and isolation.   Fatty acid mixtures can be purified in advance using preparative 
reverse-phase HPLC, low-temperature crystallization, fractional distillation, or esterification 
followed by chromatography and subsequently used in chemical reactions. Each of these 
methods suffer from drawbacks related to the inherent structural similarities of long chain 
unsaturated fatty acids, and the time- and labor-intensive protocols involved. An alternative 
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approach is to conduct a reaction with the plant oil directly invoking a chemical capture reaction 
using vanillamine (4-hydroxy-3-methoxybenzylamine), which is the starting material required to 
synthesize capsaicin analogs (Richbart et al., 2021). In this fashion, the fatty acids in the plant oil 
will be converted to five distinct fatty acid amides.  
The benefits of the chemical capture approach with plant oils are that the resulting 
products represent stable, UV-active, and chromatographically friendly compounds that can be 
easily separated, purified, and analyzed in a preparative fashion using standard methods of 
normal-phase silica gel flash column chromatography (see Figure 4). 
The reaction between vanillamine and plant oil will be conducted using a standard 
carboxylic acid-amine condensation reaction to afford a mixture of fatty acid amides (and 
represent the final capsaicin analogs containing long chain unsaturated fatty acids) in a single 
step. The five fatty acid amide products derived from the reaction will be purified (silica gel, 
ethyl acetate/hexanes mobile phase) and analyzed using mass spectrometry for confirmation of 
molecular weight and 1H- and 13C-NMR for confirmation of structure. 
 
Results and Discussion 
The first plant oil investigated was Echium seed oil (Health and Beauty Oils Center, 
Westchester, Illinois USA), which is reported to contain a mixture of five unsaturated fatty acids 
(Table 1).  Prior to exploring this reaction, saponification of the commercial oil was necessary to 
convert triacyl- and diacyglycerides to free fatty acids (Baik et al., 2015).  Echium oil was 
treated with an aqueous solution of sodium hydroxide in ethanol and subsequently acidified and 
extracted into hexanes to yield the free fatty acid mixture.   
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 Initial condensation reactions with 2-(1H-Benzotriazole-1-yl)-1,2,3,3,-tetramethyl-
uronium tetrafluoroborate (TBTU) and vanillamine afforded the crude product; the reaction 
course was monitored using thin layer chromatography (TLC) and after the reaction was 
quenched and product extracted, the crude material was initially purified on silica gel using flash 
chromatographic methods and a mobile phase consisting of ethyl acetate/hexanes to afford 
purified fractions and those molecular weights that corresponded to the anticipated products 
(MWT range 412-420 Daltons for M+H+ ions or 434-442 for M+Na+ ions) were pursued.  
Further purification using silica gel flash chromatography yielded sub fractions that were 
analyzed by MS and NMR.  The m/z product ion observed using electrospray ionization 
corresponded to a M+Na+ ion peak of m/z = 436.  The 1H NMR spectrum was indicative of new 
olefinic protons which resonate at  5.3 and 6.0 ppm.   13C NMR (1H- decoupled) analysis 
confirmed the presence of 4 additional unsaturated carbon atoms in addition to the vanillamine 
aromatic carbons and the amide carbonyl group (Figure 6). Although these carbon signals 
overlap, 13C –DEPT NMR analysis was performed to identify the C=C resonances ( 127.89, 
128.05, 130.00, 130.22).  The product isolated was suspected to correspond to Livanil (7), 
derived from the condensation of vanillamine with linoleic acid (a major fatty acid in Echium 
oil).  This was further confirmed by comparing the proton and carbon spectra with a synthetic 
sample of Linvanil (7) (prepared in our lab previously by Dr. Rama Gadepalli by condensation of 
vanillamine with linoleic acid) 
 




Figure 6:  13C NMR resonances in C=C region of spectrum obtained from Echium seed 
oil (Left panel) and from sample prepared from vanillamine and linoleic acid (Right panel) 
 
Numerous attempts were made to identify additonal N-AVAM products from Echium oil but 
purification of the constituents in the mixture proved to be difficult.  We next focused our 
attention on Ahiflower oil, and created a purification protocol that was more amenable to 
fractionation of structurally related compounds.  Twenty softgel capsules of Ahiflower oil was 
carefully cut open and the oil (about 10 g) was collected into a clean round bottom flask. A 
modified saponification method was used, that included aqueous sodium hydroxide and ethanol 
as used in the Echium oil hydrolysis, but was heated to reflux to ensure complete hydrolysis of 
the acyl-glycerides (Delmonte et al., 2018).  The purification protocol was changed to include an 
automated flash chromatography step using a Teledyne-Isco Combiflash system to purify 





Figure 7:  Purification Flowchart of N-AVAMs from Ahiflower oil. 
The product mixture resulting from the vanillamine chemistry post-workup was fractionated 
using the Combiflash system and from this Fractions D1-12 were collected and mass was 
directed to identify peaks corresponding to m/z 411 [MH+ 412], the molecular mass 
corresponding to the N-AVAM comprising stearidonic acid (compound 11).  Of these fractions, 
D8 contained material that was enriched in compounds corresponding to 11.  Fraction D8 was 
further purified using standard silica gel flash chromatography and a mobile phase consisting of 
ethyl acetate and hexanes to afford sub-fractions D8-(1-14), of which D8-2 constituted an 
enriched fraction that contained a constituent with a m/z =434 [M+Na+]-matching the expected 
molecular mass of the N-AVAM derived from stearidonic acid, in addition to higher mass peaks 




Figure 8.  Experimental (top panel) and Predicted (bottom panel) ESI+ MS spectrum (sodium 
adducts) for the N-AVAM derived from Ahiflower stearidonic acid (Fraction D8-2). 
 
1H NMR analysis of the enriched product fraction revealed a complex spectrum (Figure 9, 
partial NMR spectrum). The protons on the structure dervied from the vanillamine group are 
diagnostic for quantifying peak areas and include aromatic protons [ 6.6-6.8 ppm (3H)], the 
methylene CH2 resonance [ 4.25 ppm (2H)] and the methoxy protons [ 3.75 ppm (3H)]. The 
olefinic signals appear as muliplets centered at approximately  5.3 ppm (< 2H) and 5.7 ppm (< 
6H).  13C NMR experiments were performed to analyze the number of carbon olefinic signals, 
which was equally complex, due to the presence of at least one additional N-AVAM in the 
sample.   
 




   
Figure 10. Partial 13C-NMR spectrum of Fraction D8-2 in CDCl3 (Left panet) and Expaned C=C 
olefinic region (Right panel) 
 
Analysis of the carbon spectrum in the C=C olefinic region clearly shows one major compound 
and one minor compound. Although carbon NMR is not quantitative as per area under the peak 
integration, the combination of mass analysis, proton NMR, and carbon NMR analysis is 
suggestive of the presence of one of the target molecules, stearidonic acid amide (11).  
 
Discussion 
The results from the Echium oil experiments were disappointing, and did not result in 
identification or separation/purification of N-AVAMs resulting from SDA or GLA condensation.  
Potential pitfalls that led to the failure with the Echium oil experiments point to front-end 
problems, namely, the incomplete hydrolysis of the acyl-glycerides to free fatty acids. This is the 
most logical issue that explains the lack of identifying other N-AVAMs in the sample.  Another 
difficulty that was anticipated and observed by experiment involved purification. The fatty acid 
derivatives of vanillamine that were synthesized from the condensation reaction are structurally 
similar, and differ only in the unsaturation number and/or double bond location.   Nonetheless, 
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this thesis project represents a first step in using inexpensive and commercially available oils as 
reagents to produce high-value compounds, of particular interest in the quest to create novel 
capsaicin analogs as potentially useful therapeutic drug leads.  
 
Future Work  
Anticipating this research will be continued by others, the obvious goal that remains to be 
met is to improve the methods for purification of minor constituents from Echium or Ahiflower 
oils, including GLA and SDA.  Once this has been accomplished, the vanillamine chemical 
capture of fatty acid mixtures and subsequent purification/analysis could be extended to other 
commercially available and inexpensive dietary seed oils containing unique long unsaturated 
fatty acids, like the seeds of the Chinese violet cress (Orychophragmus violaceus) which is 
known to contain unusual C24 hydroxylated fatty acids.  (Li et al., 2018). The intended outcome 
is to create new capsaicin analogs which display improved anticancer bioactivity, a greater 













NMR spectral data 1H and 13C, were recorded in deuterated chloroform on either a Bruker 400 or 500 MHz 
spectrometer. Chemical shifts (δ) were reported relative to tetramethylsilane or solvent as an internal 
standard. Spin multiplicities were given as s (singlet), bs (broad singlet), d (doublet), t (triplet), q (quartet), 
dd (double doublet), or m (multiplet). Coupling constants (J) are reported in Hertz (Hz). Experiments 
requiring anhydrous conditions were performed using glassware that was flame-dried under vacuum and 
purged with argon. Transfer of reagents was performed by syringes equipped with stainless steel needles 
that were flushed with argon and kept under positive argon pressure until use.  Mass spectral analysis was 
performed using a Waters ZQ single quadrupole instrument and electrospray ionization in either positive 
or negative mode. Samples were analyzed by direct injection. The automated purification and mass-directed 
analysis was performed using a Teledyne-Isco Combiflash system. Thin layer chromatography (silica gel 
plates, UV detection) were used to monitor reaction progress.  Chemicals, reagents, and solvents were 
purchased from Fisher Scientific or Sigma-Aldrich.  
 
Preparation of free fatty acids from Echium seed oil 
Echium seed oil (10 g), which is claimed to be a mixture of  16% Oleic acid (18:1), 19% 
Linoleic acid (LA, 18:2), 10% γ-linolenic acid (GLA, 18:3), 30% α-linolenic acid (ALA, 18:3) 
and 13% stearidonic acid (SDA, 18:4) in the form of diacyl- and triacyl-glycerol esters was 
treated with a solution of sodium hydroxide (48 g) in distilled water (10 mL) and ethanol (30 
mL). The mixture stirred for 1 hr. Water (20 mL) was added to the saponified mixture and the 
aqueous layer containing the organic acids was acidified by adding an aqueous solution of 6 N 
HCl and adjusted to pH 1. The upper layer containing the fatty acid mixture was extracted into n-
hexane and washed twice with distilled water. The n-hexane layer containing the fatty acid 
mixture was then dried over anhydrous sodium sulfate. Then n-hexane was removed from the 
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fatty acid by evaporation in a rotary evaporator.  The residual n-hexane in the remaining fatty 
acid crude product, (A) was removed by placing the sample under high vacuum and the resulted 
colorless viscous oily residue (Yield: 8.65 g) converted to white viscous wax on cooling.  
 
Condensation reaction of Echium seed oil free fatty acids with vanillamine 
2-(1H-Benzotriazole-1-yl)-1,2,3,3,-tetramethyluronium tetrafluoroborate (TBTU, 1 equiv; 1.41 
mmol; 452 mg) was added to Echium seed oil free fatty acids (400 mg) with triethylamine (TEA, 
2 equiv; 2.82 mmol; 285.4 mg;  400 mL) in EtOAc (30 mL). After stirring for 1 h at room 
temperature, 4-hydroxy3-methoxy-benzylamine hydrochloride (vanillamine hydrochloride) (2 
equiv; 2.82 mmol; 535 mg) was added and the reaction mixture was stirred overnight. The mixture 
was washed with water then with brine, dried over anhydrous sodium sulfate, filtered and 
concentrated to give crude product (B), a pale yellow oily residue. This crude reaction product 
which was considered to be a mixture of more than one N-AVAM was subjected to purification 
using a preparative column packed with silica gel to isolate enriched fractions using a mobile phase 
consisting of 50% ethyl acetate/50% hexanes for elution. Purification afforded one enriched 
fraction that was obtained as a colorless oil. 1H NMR (500 MHz, Chloroform-d) δ 6.90 – 6.68 (m, 
3H), 6.15 – 5.89 (m, 1H), 5.55 – 5.20 (m, 3H), 4.33 (d, J = 5.6 Hz, 2H), 3.85 (s, 3H), 2.77 (d, J = 
6.6 Hz, 1H), 2.20 (t, J = 7.6 Hz, 2H), 2.04 (d, J = 4.9 Hz, 3H), 1.64 (t, J = 7.4 Hz, 2H), 1.45 – 1.20 
(m, 15H), 0.94 – 0.81 (m, 3H). 13C NMR (126 MHz, CDCl3) δ 173.09, 146.80, 145.18, 130.27, 
130.21, 130.00, 128.05, 127.89, 120.69, 114.47, 110.75, 77.37, 77.11, 76.86, 55.87, 43.50, 36.77, 





Preparation of free fatty acids from Ahiflower oil  
Twenty softgel capsules of Ahiflower oil was carefully cut open and the oil (about 10 g) was 
collected into a clean round bottom flask comprising a solution of sodium hydroxide (48 g) in 
distilled water (10 mL) and ethanol (30 mL). The mixture was refluxed with stirring for 1 hr. 
Water (20 mL) was added to the saponified mixture and the aqueous layer containing the free 
fatty acids was acidified by adding an aqueous solution of 6 N HCl and adjusted to pH 1 to 
release the free fatty acids. Litmus paper was used to measure the pH of the crude product 
intermittently throughout the titration. After the pH was brought to 1, the contents were taken 
into a separation funnel and extracted with ethyl acetate (100 ml x 2) and the organic portions 
were combined washed twice with water and then with brine, dried the organic portion with 
anhydrous sodium sulfate, filtered and evaporated under reduced pressure to yield the fatty acid 
mixture.  Mass analysis of this fatty acid mixture concentrate after saponification revealed the 
following data: MS in MeOH (ESI+): m/z [MH+] 276.45; [MNa+] 299.36 [MNa+] 302.39 
[MNa+]; 304.48 [MNa+].  
 
Condensation of Ahiflower oil free fatty acids with vanillylamine: Small scale reaction 
2-(1H-Benzotriazole-1-yl)-1,2,3,3,-tetramethyluronium tetrafluoroborate (TBTU, 1 equiv; 110 
mg) was added to a (100 mg) mixture of Ahiflower oil fatty acids and triethylamine (TEA, 2 
equiv; 135 mg) in EtOAc (11 mL). After stirring for 1 h at room temperature, 4-hydroxy3-
methoxy-benzylamine hydrochloride (vanillamine hydrochloride) (2 equiv; 0.712 mmol; 135 
mg) was added and the reaction mixture was stirred overnight. The mixture was washed with 
water (2x 12 mL), then with brine and dried over anhydrous sodium sulfate, filtered and 




Condensation of Ahiflower oil fatty acids with vanillylamine: Scaled reaction 
The reaction was repeated by reacting 2-(1H-benzotriazole-1-yl)-1,2,3,3,-
tetramethyluronium tetrafluoroborate (TBTU, 3 equiv; 348 mg) with mixture of Ahiflower oil 
fatty acids (320 mg) and triethylamine (TEA, 3 equiv;  400 mg) in EtOAc (33 mL). After stirring 
for 1 h at room temperature, 4-hydroxy3-methoxy-benzylamine hydrochloride (vanillamine 
hydrochloride) (3 equiv; 405.5 mg) was added and the reaction mixture was stirred overnight. 
The mixture was washed with water (2x 12 mL), then with brine and dried over anhydrous 
sodium sulfate, filtered and concentrated to give crude product amides as a pale yellow oily 
residue.   The crude material was subjected to automated column purification using the 
Combiflash/ Teledyne-Isco flash chromatography system resulting in isolated fractions depicted 
as D1 to D12. The D8 fraction was considered to be the major fraction (310 mg) containing the 
N-AVAMs. This D8 fraction was further subjected to meticulous gradient flash chromatography 
purification (ethyl acetate/hexanes mobile phase gradient). to yield fourteen fractions, D8-1 to 
D8-14 that contained closely overlapping constituents when monitored by TLC.  The fraction 
D8-2 was analyzed.  
 
Mass Analysis : ESI+MS: m/z 434.30 [M+Na] (calculated m/z: 434.27) 
NMR analysis:  1H NMR (500 MHz, CDCl3) δ 6.86 (d, J = 8.0 Hz, 1H), 6.80 (d, J = 1.9 Hz, 
1H), 6.76 (d, J = 1.9 Hz, 1H), 5.93 (d, J = 28.9 Hz, 2H), 5.37 (ddd, J = 6.7, 3.3, 2.0 Hz, 5H), 4.34 
(d, J = 5.6 Hz, 2H), 3.86 (s, 3H), 2.82 (td, J = 5.6, 1.8 Hz, 3H), 2.20 (dd, J = 8.5, 6.8 Hz, 2H), 
2.07 (dt, J = 11.7, 4.1 Hz, 4H), 1.75 – 1.59 (m, 2H), 1.40 – 1.21 (m, 9H), 1.03 – 0.81 (m, 3H).   
13C NMR (126 MHz, CDCl3) δ 173.05, 146.77, 145.16, 131.96, 130.28, 130.23, 128.29, 128.23, 
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127.74, 127.10, 120.73, 114.44, 110.73, 77.35, 77.10, 76.84, 55.90, 43.52, 36.80, 29.59, 29.30, 
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1H and 13C of major N-AVAM isolated from reaction of Echium seed oil and vanillamine: 






13C DEPT NMR of major N-AVAM isolated from reaction of Echium seed oil and 

















1H and 13C NMR spectra of Livanil (7)-synthetic standard produced from reaction of 






1H and 13C NMR spectra of Fraction D8-2: produced from reaction of Ahiflower oil fatty 
acids and vanillamine. 
